SIGN UP
LOG IN
L
LSB
LakeShore Biopharma Co., Ltd
1.19
-0.06-4.80%After Hours: 1.180 -0.01 -0.84%16:57 05/02 EDT
OPEN/PREV CLOSE1.180/1.250
TODAY RANGE1.174-1.260
VOL13.62K
MARKET CAP22.71M
52 WEEK RANGE1.150-11.20
AVG VOL (3M)16.84K
% TURNOVER0.07%
TURNOVER--
P/E (TTM)-0.4102
% RANGE6.91%
EPS(TTM)-2.9009
P/E(FORWARD)-0.7940
P/B0.2644
BVPS4.500
DIVIDEND--
P/S0.2854
BETA--
DIV YIELD0.00%
FREE FLOAT MKT CAP4.07M
SHARES OUTSTANDING19.08M
NEXT EARNINGS--
FREE FLOAT3.42M
LOT SIZE1
EX-DIV DATE10/04/2024
News
Press Releases
Financial Reports
Profile
Benzinga·04/10 09:26
Why ReShape Lifesciences Shares Are Trading Higher By Over 82%; Here Are 20 Stocks Moving Premarket
Benzinga·03/21 12:10
12 Health Care Stocks Moving In Friday's Pre-Market Session
TipRanks·12/19/2024 14:47
LakeShore Biopharma’s Financial Leap and Rabies Vaccine Trial Approval
Benzinga·12/16/2024 21:05
12 Health Care Stocks Moving In Monday's Pre-Market Session
TipRanks·12/13/2024 01:05
LakeShore Biopharma provides update on ongoing investigation involving Yi Zhang
TipRanks·12/12/2024 21:29
LakeShore Biopharma Faces Challenges Amid Criminal Probe into Former Chairman
TipRanks·11/07/2024 13:50
LakeShore Biopharma Advances PIKA Rabies Vaccine Approval
TipRanks·11/07/2024 13:24
LakeShore Biopharma initiates BLA submission to DRAP for PIKA rabies vaccine
Benzinga·11/05/2024 16:34
12 Health Care Stocks Moving In Tuesday's Intraday Session
TipRanks·11/01/2024 20:32
LakeShore Biopharma Announces Leadership Transition
TipRanks·10/29/2024 13:48
LakeShore Biopharma Achieves Nasdaq Compliance Milestone
Same Industry
Name/Symbol
Change%
Price
Risk Disclosure: The content of this page is not an investment advice and does not constitute any offer or solicitation to offer or recommendation of any investment product. It is for general purposes only and does not take into account your individual needs, investment objectives and specific financial circumstances. All investments involve risk and the past performance of securities, or financial products does not guarantee future results or returns. Keep in mind that while diversification may help spread risk it does not assure a profit, or protect against loss, in a down market. There is always the potential of losing money when you invest in securities, or other financial products. Investors should consider their investment objectives and risks carefully before investing. For more details, please refer to risk disclosure.
① During the campaign period, US stocks, US stocks short selling, US stock options, Hong Kong stocks, and A-shares trading will maintain at $0 commission, and no subscription/redemption fees for mutual fund transactions. $0 fee offer has a time limit, until further notice. For more information, please visit: https://www.webull.hk/pricing
Webull Securities Limited is licensed with the Securities and Futures Commission of Hong Kong (CE No. BNG700) for carrying out Type 1 License for Dealing in Securities, Type 2 License for Dealing in Futures Contracts and Type 4 License for Advising on Securities.
① During the campaign period, US stocks, US stocks short selling, US stock options, Hong Kong stocks, and A-shares trading will maintain at $0 commission, and no subscription/redemption fees for mutual fund transactions. $0 fee offer has a time limit, until further notice. For more information, please visit: https://www.webull.hk/pricing
Webull Securities Limited is licensed with the Securities and Futures Commission of Hong Kong (CE No. BNG700) for carrying out Type 1 License for Dealing in Securities, Type 2 License for Dealing in Futures Contracts and Type 4 License for Advising on Securities.
Language
English
©2025 Webull Securities Limited. All rights reserved.